Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:tenofovir_disoproxil_fumarate
gptkb:efavirenz emtricitabine |
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA 2006 |
| gptkbp:ATCCode |
J05AR06
|
| gptkbp:contraindication |
severe liver impairment
concurrent use with voriconazole |
| gptkbp:drugClass |
antiretroviral therapy
fixed-dose combination |
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Atripla
|
| gptkbp:indication |
treatment of HIV-1 infection in adults
treatment of HIV-1 infection in children over 12 years |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Merck_&_Co.
gptkb:Gilead_Sciences gptkb:Bristol-Myers_Squibb |
| gptkbp:pregnancyCategory |
gptkb:C_(AU)
D (US) |
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
gptkb:depression
nausea dizziness rash insomnia |
| gptkbp:usedFor |
HIV infection
|
| gptkbp:website |
https://www.atripla.com/
|
| gptkbp:bfsParent |
gptkb:efavirenz
|
| gptkbp:bfsLayer |
6
|